Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Teva Pulls Wellbutrin Generic

Filed October 5th, 2012 Laurie

Teva Pharmaceutical Industries is pulling its version of the antidepressant drug Wellbutrin XL, after testing performed by the U.S. Food & Drug Administration (FDA) determined the generic is not equivalent to the branded drug.

The agency will now require other generic companies to test the efficacy of their own branded drugs.

Questions about the generic drug, known as Budeprion XL, first surfaced in 2007 when patients began complaining that it was not as effective as the branded Wellbutrin. said that a team of pharmacists and Consumer Labs compared the extended-release brand with Teva’s generic and found the generic released the drug’s active ingredient much faster, and not to the same extent, proving the Teva generic equivalent was not an equivalent at all.

The new findings could mean a sales boost for the brand-name Wellbutrin XL, and could lend to credence to complaints about other generic drugs. The FDA might also be forced to improve upon its generic approval standards, said FiercePharma.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!